xmlui.ArtifactBrowser.ConfigurableBrowse.title.metadata.subjectArtikkelit"SYST-EUR"

Ambulatory pressure decreases a long-term placebo treatment in older patients with isolated systolic hypertension

Staessen JA; This L; Clement D; Davidson C; Fagard R; Lehtonen A; Mancia G; Palatini P; Parati G; Webster J; Amery A; behalf of the SYST-EUR Investigators Study Group; Sarti C; Tuomilehto J
J Hypertens (1994)

Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertnsion

Staessen JA; Thijs L; O'Brien ET; Bulpitt CJ; De Leeuw PW; Fagard RH; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J; Safar ME; SYST-EUR Trial Investigators
AM J HYPERTENS (2002)

Associations of orthostatic blood pressure fall in older patients with isolated systolic hypertension

Vanhanen H; Lutgarde T; Birkenhäger W; Tilvis R; Sarti C; Tuomilehto J; Bulpitt C; Fagard R; Staessen JA; on behalf of the Syst-Eur Investigators
J Hypertens (1996)

Calcium channel blockade and cardiovascular prognosis in the European trial on isolated systolic hypertension

Staessen JA; Thijs L; Fagard RH; Birkenhäger WH; Arabidze G; Babeanu S; Gil-Extremera B; Bulpitt CJ; Davidson C; De Leeuw PW; Efstratopoulus AD; Fletcher AE; Fogari R; Jääskivi M; Kawecka-Jaszcz K; Nachev C; Petrie JC; Seux ML; Tuomilehto J; Webster J; Yodfat Y; SYST-EUR Trial Investigators; Sarti C
Hypertension (1998)

Clinical trials with ambulatory blood pressure monitoring: Fewer patients needed?

Staessen J; Thijs L; Mancia G; Parati G; behalf of the SYST-EUR Investigators; Tuomilehto J; Sarti C; Penttilä L
Lancet (1994)

Correlates of cognitive status of old patients with isolated systolic hypertension: the Syst-Eur Vascular Dementia Project

Seux M-L; Thijs L; Forette F; Staessen JA; Birkenhäger WH; Bulpitt CJ; Girerd X; Jääskivi M; Vanhanen H; Kivinen P; Yodfat Y; Vänskä O; Antikainen R; Laks T; Webster JR; Hakamäki T; Lehtomäki E; Lilov E; Grigorov M; Janculova K; Halonen K; Kohonen-Jalonen P; Kermowa R; Nachev C; Tuomilehto J; on behalf of SYST-EUR Investigators; Sarti C
J Hypertens : 7 (1998)

Determining the trough-to-peak ratio in parallel-group trials

Staessen JA; Thijs L; Bijttebier G; Clement D; Palatini P; Rodicio J; Rosenfeld J; Fagard R; behalf of the SYST-EUR Trial Investigators; Tuomilehto J; Sarti C
Hypertension (1997)

Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension

Tuomilehto J; Rastenyte D; Birkenhäger WH; Thijs L; Antikainen R; Bulpitt CJ; Fletcher AE; Forette F; Goldhaber A; Palatini P; Sarti C; Fagard R; Syst-Eur Trial Investigators
N Engl J Med : 9 (1999)

Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial

Staessen JA; Thijs L; Fagard R; Celis H; Birgenhäger WH; Bulpitt CJ; de Leeuw PW; Fletcher AE; Forette F; Leonetti G; McCormack P; Nachev C; O'Brien E; Rodicio JL; Rosenfeld J; Sarti C; Tuomilehto J; Webster J; Yodfat Y; Zanchetti A; TheSys-Eur Trial Investigators
J Hypertens (2004)

Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension

Voyaki SM; Staessen JA; Thijs L; Wang JG; Efstratopoulos AD; Birkenhäger WH; De Leeuw PW; Leonetti G; Nachev C; Rodicio JL; Tuomilehto J; Fagard R; The Systolic Hypertension in Europe (Syst-Eur) Trial Investi
J Hypertens (2001)

How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-up Study (SYST-EUR 2)

Thijs L; Staessen JA; Beleva S; Birkenhäger WH; Bulpitt CJ; Celis H; Fletcher AE; Kermova R; Leonetti G; Laks T; Mantov S; Nachev C; Sarti C; Tuomilehto J; Fagard RH; Systolic Hypertension in Europe Investigators
Current Controlled Trials in Cardiovascular Medicine : 6 (2001)

Interaction between nonsteroidal anti-inflammatory drug intake and calcium-channel blocker-based antihypertensive treatment in the Syst-Eur trial

Celis H; Thijs L; Staessen JA; Birkenhäger WH; Bulpitt CJ; De Leeuw PW; Leonetti G; Nachev C; Tuomilehto J; Fagard RH; Syst-Eur Investigators
J Hum Hypertens (2001)

Limitations of the difference between clinic and daytime blood pressure as a surrogate measure of the 'white coat' effect

Parati G; Omboni S; Staessen J; Thijs L; Fagard R; Ulian L; Mancia G; Syst-Eur Investigators; Sarti C; Tuomilehto J
J Hypertens : 1 (1998)

Nitrendipine in older patients with isolated systolic hypertension: second progress report on the SYST-EUR trial

Slovick D; Staessen J; Bert P; Bulpitt C; de Cort P; Fagard R; Fletcher A; Kivinen P; Lehtomäki E; Leonetti G; Rodicio J; Rosenfeld J; Thijs L; Tozzi N; Tuomilehto J; Vanhanen H; Vänskä O; Webster J; Yodfat Y; SYST-EUR Investigators; Sarti C
J Hum Hypertens (1993)

Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension

Staessen J; Thijs L; Fagard R; Clement D; De Leeuw PW; Mancia G; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J; Systolic Hypertension in Europe Trial Investigators; Sarti C
JAMA : 6 (1999)

Prevalence and persistency of orthostatic blood pressure fall in older patients with isolated systolic hypertension

Vanhanen H; Thijs L; Birkenhäger W; Bulpitt C; Tilvis R; Sarti C; Tuomilehto J; Staessen JA; on behalf of the Syst-Eur Investigators
J Hum Hypertens (1996)

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial

Forette F; Seux ML; Staessen JA; Thijs L; Birkenhäger WH; Babarskiene MR; Babeanu S; Bossini A; Gil-Extremera B; Girerd X; Laks T; Lilov E; Moisseyev V; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Fagard R; on behalf of the Syst-Eur Investigators; Sarti C
Lancet : 9137 (1998)

Quality of life of elderly patients with isolated systolic hypertension: baseline data from the Syst-Eur Trial

Fletcher AE; Bulpitt CJ; Tuomilehto J; Browne J; Bossini A; Kawecka-Jaszcz K; Kivinen P; O´Brien E; Staessen J; Thijs L; Vänskä O; Vanhanen H; on behalf of the Syst-Eur Trial Investigators; Sarti C
J Hypertens (1998)

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension

Staessen JA; Fagard R; Thijs L; Arabidze GG; Birkenhänger WH; Bulpitt CJ; de Leeuw P; Dollery CT; Fletcher AE; Forette F; Leonetti G; Nachev C; Rosenfeld J; Rodicio JL; Tuomilehto J; Zanchetti A; for the Syst-Eur Trial Investigators; Sarti C
Lancet (1997)

Subgroup and Pre-Protocol Analysis of the Randomized European Trial on Isolated Systolic Hypertension in the Elderly

Staessen JA; Fagard R; Thijs L; Celis H; Birkenhager WH; Bulpitt CJ; de Leeuw PW; Fletcher AE; Babarskiene M-R; Forette F; Kocemba J; Laks T; Leonetti G; Nachev C; Petrie JC; Tuomilehto J; Vanhanen H; Webster J; Yodfat Y; Zanchetti A; for the Systolic Hypertension in Europe Trial Investigators; Sarti C
Arch Intern Med (1998)

Artikkelit - Selaus asiasanan mukaan "SYST-EUR"

Ambulatory pressure decreases a long-term placebo treatment in older patients with isolated systolic hypertension ﻿

Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertnsion ﻿

Associations of orthostatic blood pressure fall in older patients with isolated systolic hypertension ﻿

Calcium channel blockade and cardiovascular prognosis in the European trial on isolated systolic hypertension ﻿

Clinical trials with ambulatory blood pressure monitoring: Fewer patients needed? ﻿

Correlates of cognitive status of old patients with isolated systolic hypertension: the Syst-Eur Vascular Dementia Project ﻿

Determining the trough-to-peak ratio in parallel-group trials ﻿

Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension ﻿

Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial ﻿

Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension ﻿

How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-up Study (SYST-EUR 2) ﻿

Interaction between nonsteroidal anti-inflammatory drug intake and calcium-channel blocker-based antihypertensive treatment in the Syst-Eur trial ﻿

Limitations of the difference between clinic and daytime blood pressure as a surrogate measure of the 'white coat' effect ﻿

Nitrendipine in older patients with isolated systolic hypertension: second progress report on the SYST-EUR trial ﻿

Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension ﻿

Prevalence and persistency of orthostatic blood pressure fall in older patients with isolated systolic hypertension ﻿

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial ﻿

Quality of life of elderly patients with isolated systolic hypertension: baseline data from the Syst-Eur Trial ﻿

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension ﻿

Subgroup and Pre-Protocol Analysis of the Randomized European Trial on Isolated Systolic Hypertension in the Elderly ﻿